UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
Science (American Association for the Advancement of Science), ISSN 0036-8075, 03/2019, Volume 363, Issue 6432, pp. 1230 - 1234
Science & Technology - Other Topics | Multidisciplinary Sciences | Science & Technology | History | Population genetics | Genomics | Analysis | Substructures | Iron Age | Admixtures | Prehistoric | Iron | Genomes | Y chromosomes | Archaeology | Gene flow | Genetic analysis | Linguistics | Chromosomes | Deoxyribonucleic acid--DNA
Journal Article
Hepatology (Baltimore, Md.), ISSN 0270-9139, 06/2017, Volume 65, Issue 6, pp. 1810 - 1822
Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Multivariate Analysis | Predictive Value of Tests | Prognosis | Humans | Middle Aged | Hepatitis C, Chronic - physiopathology | Liver Cirrhosis - mortality | Hepacivirus - genetics | Male | Hepatitis C, Chronic - mortality | Cause of Death | Ribavirin - administration & dosage | Aged, 80 and over | Adult | End Stage Liver Disease - drug therapy | Female | Registries | Retrospective Studies | Hepacivirus - drug effects | Liver Function Tests | Severity of Illness Index | Liver Cirrhosis - drug therapy | Risk Assessment | Kaplan-Meier Estimate | Proportional Hazards Models | Logistic Models | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Disease Progression | End Stage Liver Disease - pathology | Spain | End Stage Liver Disease - mortality | Liver Cirrhosis - virology | Sofosbuvir - administration & dosage | Survival Analysis | Aged | Liver Cirrhosis - physiopathology | Cohort Studies | End Stage Liver Disease - virology | Cirrhosis | Antiviral agents | Hepatitis | Liver diseases | Chronic infection | Data processing | Interferon | Hepatitis C | Patients | Index Medicus
Journal Article
Journal of hepatology, ISSN 0168-8278, 2017, Volume 66, Issue 6, pp. 1138 - 1148
Gastroenterology and Hepatology | Antiviral agents | Ombitasvir | Ritonavir | Ledipasvir | Real-world | Genotype 1 | Paritaprevir | Sustained virologic response | Hepatitis C, Chronic | Sofosbuvir | Dasabuvir | Randomized controlled trials | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Uridine Monophosphate - administration & dosage | Humans | Middle Aged | Hepatitis C, Chronic - physiopathology | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Carbamates - administration & dosage | Neoplasm Recurrence, Local - etiology | Liver Neoplasms - etiology | Young Adult | Uracil - administration & dosage | Benzimidazoles - administration & dosage | Ribavirin - administration & dosage | Aged, 80 and over | Adult | Female | Fluorenes - administration & dosage | Carcinoma, Hepatocellular - etiology | Retrospective Studies | Drug Therapy, Combination | Glomerular Filtration Rate | Ritonavir - administration & dosage | Antiviral Agents - therapeutic use | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Spain | Anilides - administration & dosage | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Macrocyclic Compounds - administration & dosage | Sustained Virologic Response | Sulfonamides - administration & dosage | Cohort Studies | Uracil - analogs & derivatives | Genetic aspects | Safety and security measures | Hepatitis C virus | Clinical trials | Chronic infection | Data processing | Hepatocellular carcinoma | Multivariate analysis | Patients | Clinical outcomes | Ribavirin | Genotype & phenotype | Cohort analysis | Fibrosis | Safety | Drug therapy | Hepatitis C | Antiviral drugs | Genotypes | Index Medicus
Journal Article
European journal of clinical microbiology & infectious diseases, ISSN 0934-9723, 02/2020, Volume 39, Issue 2, pp. 309 - 323
Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Regression coefficients | Health risks | Derivation | Infections | Emergency medical care | Drug resistance | Risk analysis | Risk factors | Microorganisms | Regression models | Infectious diseases | Prediction models | Antibiotics | Emergency medical services | Index Medicus
Journal Article
Journal of allergy and clinical immunology, ISSN 0091-6749, 2012, Volume 130, Issue 5, pp. 1200 - 1202
Allergy and Immunology | Allergy | Immunology | Life Sciences & Biomedicine | Science & Technology | Skin Tests | Eosinophilic Esophagitis - diagnosis | Eosinophilic Esophagitis - diet therapy | Humans | Middle Aged | Male | Eosinophils - immunology | Food Hypersensitivity - diet therapy | Food Hypersensitivity - complications | Young Adult | Eosinophilic Esophagitis - complications | Esophagus - pathology | Allergens - immunology | Adolescent | Adult | Diet Therapy - methods | Female | Esophagus - immunology | Food Hypersensitivity - diagnosis | Medical tests | Skin | Food allergies | Legumes | Dysphagia | Patients | Allergies | Fruits | Food | Rice | Milk | Index Medicus | Abridged Index Medicus | Indexing in process
Journal Article
Journal of hepatology, ISSN 0168-8278, 11/2019, Volume 71, Issue 5, pp. 876 - 888
Resistance testing | RASs | Treatment failure | HCV | Resistance-associated substitution | Ribavirin | Direct-acting antivirals | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Anilides - therapeutic use | Prospective Studies | Hepatitis C - drug therapy | Humans | Middle Aged | Fluorenes - therapeutic use | Hepacivirus - genetics | Male | Cyclopropanes - therapeutic use | Hepatitis C - epidemiology | Ritonavir - therapeutic use | Female | Imidazoles - therapeutic use | Lactams, Macrocyclic - therapeutic use | Drug Therapy, Combination | Benzimidazoles - therapeutic use | Sofosbuvir - therapeutic use | Antiviral Agents - pharmacology | Proline - analogs & derivatives | Antiviral Agents - therapeutic use | Ribavirin - therapeutic use | Viral Nonstructural Proteins - genetics | Genotype | Proline - therapeutic use | Retreatment | Drug Resistance, Viral - genetics | Sulfonamides - therapeutic use | Spain - epidemiology | Hepatitis C - virology | Sustained Virologic Response | Carbamates - therapeutic use | Viral Nonstructural Proteins - antagonists & inhibitors | Disease resistance | Antiviral agents | Hepatitis | Ritonavir | New combinations | Interferon | Hepatitis C | Index Medicus
Journal Article
Annals of clinical microbiology and antimicrobials, ISSN 1476-0711, 10/2019, Volume 18, Issue 1, pp. 30 - 30
Bloodstream infection | Endocarditis | Dalbavancin | Life Sciences & Biomedicine | Microbiology | Science & Technology | Length of Stay | Endocarditis, Bacterial - drug therapy | Humans | Middle Aged | Male | Treatment Outcome | Teicoplanin - therapeutic use | Drug-Related Side Effects and Adverse Reactions - epidemiology | Drug-Related Side Effects and Adverse Reactions - pathology | Teicoplanin - adverse effects | Anti-Bacterial Agents - therapeutic use | Sepsis - drug therapy | Cost-Benefit Analysis | Female | Aged | Anti-Bacterial Agents - adverse effects | Retrospective Studies | Gram-Positive Bacterial Infections - drug therapy | Teicoplanin - analogs & derivatives | Infective endocarditis | Sepsis | Gram-positive bacterial infections | Drug therapy | Patient outcomes | Index Medicus
Journal Article